MS Avatar
MS
Created by admin on Jul, 15 2015 with 1 Members

MS

4
The Canadian Agency for Drugs and Technologies in Health (CADTH) is conducting a drug review for an MS treatment called peginterferon beta-1a. Marketed as Plegridy(TM) by Biogen, this drug is a new formulation of interferon beta-1a that enables it to last longer in the body, reducing the dosing schedule.
What is Trendrils?

Trendrils is a news aggregator website. ALL net proceeds from this website will be donated towards the Multiple Sclerosis Society or MS research.

Latest Comments